Recce Pharmaceuticals Ltd (ASX:RCE)

Australia · Delayed Price · Currency is AUD

0.2900

+0.0100 (3.57%)

Oct 16, 2026, 4:10 PM AEST

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Research and Development of Pharmaceutical Drugs	9.47M	7.51M	5.03M	4.37M	3.08M
Total	9.47M	7.51M	5.03M	4.37M	3.08M

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Australia	7.36M	5.29M	3.83M	4.34M	2.84M
USA	1.97M	1.65M	1.37M	58.47K	317.16K
UK	43.45K	26.84K	26.81K	32.07K	23.01K
Unallocated	561.33K	733.30K	-	-	-
Total	9.94M	7.70M	5.24M	4.43M	3.18M